Table 2.
Factors associated with repeat visits: results of chi-square analyses
| Variable* | Had a repeat visit n = 177 n (%) |
Did not have a repeat visit n = 1296 n (%) |
Chi-square P value |
|---|---|---|---|
| Sex | |||
| Female | 70 (14.6) | 410 (85.4) | |
| Male | 107 (10.8) | 886 (89.2) | 0.495 |
| Median age (years)† | |||
| Men | 24.0 | 24.0 | 0.246 |
| Women | 22.0 | 22.0 | 0.333 |
| Referred to the clinic | |||
| Men: yes | 2 (1.9) | 104 (11.7) | 0.001 |
| Women: yes | 3 (4.3) | 75 (18.3) | 0.002 |
| Type of session: individual (versus couple) | |||
| Men: individual | 102 (95.3) | 801 (93.4) | 0.433 |
| Women: individual | 62 (88.6) | 286 (73.0) | 0.007 |
| Attending clinic as contact of someone with STI | |||
| Men: yes | 4 (3.9) | 32 (3.9) | 0.999 |
| Women: yes | 7 (10.3) | 75 (20.4) | 0.062 |
| Self-reported HIV status | |||
| Men: self-reported HIV-positive | 12 (14.3) | 42 (6.3) | 0.008 |
| Women: self-reported HIV-positive | 6 (9.1) | 35 (10.6) | 0.712 |
| Number of sexual partners, past 30 days | |||
| Men | |||
| None | 30 (28.0) | 175 (19.8) | |
| One | 51 (47.7) | 576 (65.3) | |
| Two or more | 26 (24.3) | 131 (14.9) | 0.001 |
| Women | |||
| None | 26 (37.1) | 106 (26.1) | |
| One | 44 (62.9) | 290 (71.4) | |
| Two or more | 0 (0.0) | 10 (2.5) | 0.101 |
| Symptoms and exam findings in men | |||
| Current urethral discharge, by history or exam | 41 (38.2) | 358 (40.5) | 0.671 |
| Urethral discharge past 6 months | 12 (11.4) | 34 (3.9) | 0.001 |
| Dysuria | 52 (49.1) | 395 (44.7) | 0.398 |
| Genital ulcer, history or exam | 22 (20.6) | 168 (19.0) | 0.695 |
| Balanitis | 3 (2.8) | 67 (7.7) | 0.072 |
| Circumcised | 18 (16.8) | 189 (21.7) | 0.244 |
| Diagnoses in men | |||
| Urethritis | 52 (48.6) | 400 (45.4) | 0.531 |
| Genital ulcer disease: clinically herpetic | 17 (15.9) | 100 (11.4) | 0.180 |
| Genital ulcer disease: clinically non-herpetic | 3 (3.0) | 40 (5.4) | 0.324 |
| Balanitis, posthitis | 10 (9.4) | 114 (13.0) | 0.279 |
| Pharmacological treatment in men | |||
| Cefixime | 47 (44.8) | 382 (43.5) | 0.799 |
| Doxycycline | 48 (45.3) | 402 (46.3) | 0.841 |
| Metronidazole | 3 (2.8) | 30 (3.5) | 1.000 |
| Symptoms in women | |||
| Genital ulcer | 2 (2.0) | 43 (10.6) | 0.060 |
| Lower abdominal pain | 13 (18.8) | 113 (28.5) | 0.099 |
| Women: pregnant or suspected pregnant | 11 (16.9) | 29 (7.8) | 0.022 |
| Diagnoses in women | |||
| Vaginitis | 43 (63.2) | 202 (51.7) | 0.077 |
| Cervicitis | 3 (4.4) | 40 (10.2) | 0.129 |
| Pelvic inflammatory disease | 2 (3.0) | 34 (8.7) | 0.113 |
| Genital ulcer disease: clinically herpetic | 1 (1.5) | 20 (5.1) | 0.202 |
| Genital ulcer disease: clinically non-herpetic | 1 (1.6) | 8 (2.1) | 0.789 |
| Pharmacological treatment in women | |||
| Cefixime | 8 (11.4) | 144 (36.0) | 0.001 |
| Doxycycline | 11 (15.7) | 135 (33.6) | 0.003 |
| Metronidazole | 9 (13.0) | 101 (25.0) | 0.030 |
Not all cells sum to n due to missing responses; Fisher’s exact test used where cell size ≤5
*
All findings refer to initial visit, except for completed prior treatment;
†
Median age compared between groups by Wilcoxon rank sum test